Reverie Labs founders Jonah Kallenbach and Ankit Gupta

Roche and Genen­tech's lat­est AI col­lab­o­ra­tor rais­es $25M Se­ries A to rein­vent one of the old­est can­cer tar­gets

Jon­ah Kallen­bach spent the sum­mer be­fore his se­nior year with An­ton, the hulk­ing flu­o­res­cent su­per­com­put­er housed in the mid­town Man­hat­tan of­fices of hedge fund D.E. Shaw. Armed with 512 proces­sors run­ning in par­al­lel, it’s been used since 2008 to probe some of the biggest ques­tions in pro­tein fold­ing and struc­ture.

Kallen­bach can’t talk much about what he worked on, but he was hooked, and af­ter his last year at Har­vard, he want­ed to go in­to drug de­vel­op­ment. But when he went look­ing for phar­ma roles, he found few of the com­pa­nies had space for com­pu­ta­tion­als. Or they had space, but that space was small and cor­doned off from the rest of a mas­sive or­ga­ni­za­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.